# Efficacy of Kangliuwan for Recurrent Grade IV Glioma

> **NCT03949192** · — · UNKNOWN · sponsor: **Xuanwu Hospital, Beijing** · enrollment: 20 (estimated)

## Conditions studied

- Glioma of Brain
- Recurrence

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03949192
- **Lead sponsor:** Xuanwu Hospital, Beijing
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-06-28
- **Primary completion:** 2021-06
- **Final completion:** 2021-06
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2020-05-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03949192

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03949192, "Efficacy of Kangliuwan for Recurrent Grade IV Glioma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03949192. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*